financetom
Business
financetom
/
Business
/
Mesoblast Appoints James O'Brien CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mesoblast Appoints James O'Brien CFO
Nov 17, 2025 2:19 AM

04:43 AM EST, 11/17/2025 (MT Newswires) -- Mesoblast (MESO) said Monday it has appointed James O'Brien as its chief financial officer.

O'Brien previously worked at different pharmaceutical companies, including Bristol-Myers Squibb (BMY) and Cognition Therapeutics (CGTX), the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
A.k.a. Brands Expects Q4 Net Sales of $159 Million; Names CEO, CFO; Shares Up Pre-Bell
A.k.a. Brands Expects Q4 Net Sales of $159 Million; Names CEO, CFO; Shares Up Pre-Bell
Jan 13, 2025
09:11 AM EST, 01/13/2025 (MT Newswires) -- A.k.a. Brands Holding (AKA) on Monday reported preliminary Q4 net sales of about $159 million, up from $148.9 million a year earlier. Analysts polled by FactSet expect $154 million. In a separate statement, the company said that Ciaran Long has been named chief executive, effective immediately. Long has been interim CEO and chief...
Mexican restaurant operator Alsea taps Starbucks France head as next CEO
Mexican restaurant operator Alsea taps Starbucks France head as next CEO
Jan 13, 2025
MEXICO CITY, Jan 13 (Reuters) - Mexican restaurant operator Alsea on Monday said that its board had named Christian Gurria, who heads the firm's Starbucks ( SBUX ) operations in France and the Benelux region, as its next chief executive. Alsea, which also operates chains such as Domino's Pizza and Burger King, added in a filing that Gurria would assume...
Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion
Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion
Jan 13, 2025
(Reuters) - Eli Lilly ( LLY ) said on Monday it would acquire cancer therapy developer Scorpion Therapeutics for $2.5 billion in cash. ...
Goldman Sachs announces plans for new capital solutions unit
Goldman Sachs announces plans for new capital solutions unit
Jan 13, 2025
(Reuters) - Goldman Sachs ( GS ) on Monday announced plans to combine key business segments under a single unit named 'Capital Solutions Group,' to grow in private credit, private equity and other asset classes. (Reporting by Manya Saini in Bengaluru; Editing by Shinjini Ganguli) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved